141 related articles for article (PubMed ID: 36711815)
21. Cognitive-behavioral phenotypes of Williams syndrome are associated with genetic variation in the GTF2I gene, in a healthy population.
Crespi BJ; Hurd PL
BMC Neurosci; 2014 Nov; 15():127. PubMed ID: 25429715
[TBL] [Abstract][Full Text] [Related]
22. Cannabinoid signaling modulation through JZL184 restores key phenotypes of a mouse model for Williams-Beuren syndrome.
Navarro-Romero A; Galera-López L; Ortiz-Romero P; Llorente-Ovejero A; de Los Reyes-Ramírez L; Bengoetxea de Tena I; Garcia-Elias A; Mas-Stachurska A; Reixachs-Solé M; Pastor A; de la Torre R; Maldonado R; Benito B; Eyras E; Rodríguez-Puertas R; Campuzano V; Ozaita A
Elife; 2022 Oct; 11():. PubMed ID: 36217821
[TBL] [Abstract][Full Text] [Related]
23. Reduced fear and aggression and altered serotonin metabolism in Gtf2ird1-targeted mice.
Young EJ; Lipina T; Tam E; Mandel A; Clapcote SJ; Bechard AR; Chambers J; Mount HT; Fletcher PJ; Roder JC; Osborne LR
Genes Brain Behav; 2008 Mar; 7(2):224-34. PubMed ID: 17680805
[TBL] [Abstract][Full Text] [Related]
24. The role of GTF2IRD1 in the auditory pathology of Williams-Beuren Syndrome.
Canales CP; Wong AC; Gunning PW; Housley GD; Hardeman EC; Palmer SJ
Eur J Hum Genet; 2015 Jun; 23(6):774-80. PubMed ID: 25248400
[TBL] [Abstract][Full Text] [Related]
25. Association of mouse Dlg4 (PSD-95) gene deletion and human DLG4 gene variation with phenotypes relevant to autism spectrum disorders and Williams' syndrome.
Feyder M; Karlsson RM; Mathur P; Lyman M; Bock R; Momenan R; Munasinghe J; Scattoni ML; Ihne J; Camp M; Graybeal C; Strathdee D; Begg A; Alvarez VA; Kirsch P; Rietschel M; Cichon S; Walter H; Meyer-Lindenberg A; Grant SG; Holmes A
Am J Psychiatry; 2010 Dec; 167(12):1508-17. PubMed ID: 20952458
[TBL] [Abstract][Full Text] [Related]
26. Speech delay and autism spectrum behaviors are frequently associated with duplication of the 7q11.23 Williams-Beuren syndrome region.
Berg JS; Brunetti-Pierri N; Peters SU; Kang SH; Fong CT; Salamone J; Freedenberg D; Hannig VL; Prock LA; Miller DT; Raffalli P; Harris DJ; Erickson RP; Cunniff C; Clark GD; Blazo MA; Peiffer DA; Gunderson KL; Sahoo T; Patel A; Lupski JR; Beaudet AL; Cheung SW
Genet Med; 2007 Jul; 9(7):427-41. PubMed ID: 17666889
[TBL] [Abstract][Full Text] [Related]
27. The nuclear localization pattern and interaction partners of GTF2IRD1 demonstrate a role in chromatin regulation.
Carmona-Mora P; Widagdo J; Tomasetig F; Canales CP; Cha Y; Lee W; Alshawaf A; Dottori M; Whan RM; Hardeman EC; Palmer SJ
Hum Genet; 2015 Oct; 134(10):1099-115. PubMed ID: 26275350
[TBL] [Abstract][Full Text] [Related]
28. Williams syndrome deletions and duplications: Genetic windows to understanding anxiety, sociality, autism, and schizophrenia.
Crespi BJ; Procyshyn TL
Neurosci Biobehav Rev; 2017 Aug; 79():14-26. PubMed ID: 28499504
[TBL] [Abstract][Full Text] [Related]
29. Atypical deletion of Williams-Beuren syndrome reveals the mechanism of neurodevelopmental disorders.
Zhou J; Zheng Y; Liang G; Xu X; Liu J; Chen S; Ge T; Wen P; Zhang Y; Liu X; Zhuang J; Wu Y; Chen J
BMC Med Genomics; 2022 Apr; 15(1):79. PubMed ID: 35379245
[TBL] [Abstract][Full Text] [Related]
30. Williams syndrome: a genetic deletion disorder presenting clues to the biology of sociability and clinical challenges of hypersociability.
Deutsch SI; Rosse RB; Schwartz BL
CNS Spectr; 2007 Dec; 12(12):903-7. PubMed ID: 18163035
[TBL] [Abstract][Full Text] [Related]
31. An Exploration of Social Cognition in Children with Different Degrees of Genetic Deletion in Williams Syndrome.
Serrano-Juárez CA; Prieto-Corona B; Rodríguez-Camacho M; Venegas-Vega CA; Yáñez-Téllez MG; Silva-Pereyra J; Salgado-Ceballos H; Arias-Trejo N; De León Miranda MA
J Autism Dev Disord; 2021 May; 51(5):1695-1704. PubMed ID: 32812194
[TBL] [Abstract][Full Text] [Related]
32. SUMOylation of GTF2IRD1 regulates protein partner interactions and ubiquitin-mediated degradation.
Widagdo J; Taylor KM; Gunning PW; Hardeman EC; Palmer SJ
PLoS One; 2012; 7(11):e49283. PubMed ID: 23145142
[TBL] [Abstract][Full Text] [Related]
33. An atypical 7q11.23 deletion in a normal IQ Williams-Beuren syndrome patient.
Ferrero GB; Howald C; Micale L; Biamino E; Augello B; Fusco C; Turturo MG; Forzano S; Reymond A; Merla G
Eur J Hum Genet; 2010 Jan; 18(1):33-8. PubMed ID: 19568270
[TBL] [Abstract][Full Text] [Related]
34. Genetic contributions to visuospatial cognition in Williams syndrome: insights from two contrasting partial deletion patients.
Broadbent H; Farran EK; Chin E; Metcalfe K; Tassabehji M; Turnpenny P; Sansbury F; Meaburn E; Karmiloff-Smith A
J Neurodev Disord; 2014; 6(1):18. PubMed ID: 25057328
[TBL] [Abstract][Full Text] [Related]
35. GTF2IRD1 regulates transcription by binding an evolutionarily conserved DNA motif 'GUCE'.
Thompson PD; Webb M; Beckett W; Hinsley T; Jowitt T; Sharrocks AD; Tassabehji M
FEBS Lett; 2007 Mar; 581(6):1233-42. PubMed ID: 17346708
[TBL] [Abstract][Full Text] [Related]
36. GTF2IRD1 in craniofacial development of humans and mice.
Tassabehji M; Hammond P; Karmiloff-Smith A; Thompson P; Thorgeirsson SS; Durkin ME; Popescu NC; Hutton T; Metcalfe K; Rucka A; Stewart H; Read AP; Maconochie M; Donnai D
Science; 2005 Nov; 310(5751):1184-7. PubMed ID: 16293761
[TBL] [Abstract][Full Text] [Related]
37. Oxytocin receptor activation does not mediate associative fear deficits in a Williams Syndrome model.
Nygaard KR; Swift RG; Glick RM; Wagner RE; Maloney SE; Gould GG; Dougherty JD
Genes Brain Behav; 2022 Jan; 21(1):e12750. PubMed ID: 33978321
[TBL] [Abstract][Full Text] [Related]
38. An atypical deletion of the Williams-Beuren syndrome interval implicates genes associated with defective visuospatial processing and autism.
Edelmann L; Prosnitz A; Pardo S; Bhatt J; Cohen N; Lauriat T; Ouchanov L; González PJ; Manghi ER; Bondy P; Esquivel M; Monge S; Delgado MF; Splendore A; Francke U; Burton BK; McInnes LA
J Med Genet; 2007 Feb; 44(2):136-43. PubMed ID: 16971481
[TBL] [Abstract][Full Text] [Related]
39. Williams syndrome: cognition, personality, and adaptive behavior.
Mervis CB; Klein-Tasman BP
Ment Retard Dev Disabil Res Rev; 2000; 6(2):148-58. PubMed ID: 10899809
[TBL] [Abstract][Full Text] [Related]
40. An In Vivo Gain-of-Function Screen Identifies the Williams-Beuren Syndrome Gene GTF2IRD1 as a Mammary Tumor Promoter.
Huo Y; Su T; Cai Q; Macara IG
Cell Rep; 2016 Jun; 15(10):2089-2096. PubMed ID: 27239038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
